This has been a banner week for Michigan-centric news pertaining to the development of driverless vehicles.
On Wednesday, Google announced in a Google+ post that, after placing a team of employees in the metro Detroit area for “the past few years,”... Read more »
Dallas—How can you disrupt the accelerator?
That’s the question Tech Wildcatters asked themselves following pitch day last year. “Instead of putting everybody in a one-size-fits-all program, instead of giving a trophy on day one, we decided to make it more... Read more »
San Antonio — [Updated 1 p.m. See below.] Virtual reality headset maker Merge Labs has raised $10.1 million in new equity funding, according to a filing with the U.S. Securities and Exchange Commission.
The company, which sells virtual reality... Read more »
Beneath the carefully rehearsed pitches, corny one-liners, and overall pomp and circumstance at Techstars Boston’s 10th demo day Wednesday night, it’s clear that the startup accelerator’s local outpost continues to build solid (if not always flashy) businesses.
It’s been seven years... Read more »
Schizophrenia affects millions of people around the world, which is why any prospective treatment that advances garners close attention. Minerva Neurosciences jumped into the spotlight this morning when an experimental schizophrenia drug it’s developing showed some promise in a mid-stage trial,... Read more »
Every June, Xconomy holds a big Boston event looking at the region’s innovation future. This year is no different, but some big changes are in the air for the Boston tech and life sciences communities—and we retooled our event to explore... Read more »
Usually when a biotech company makes a large fundraising announcement, the cash is committed to taking a specific drug through clinical trials. Arrivo BioVentures has secured $49 million in capital to first find the drugs to develop.
The approach is similar... Read more »
Computers can beat humans at games like chess and Go. They are obviously faster than us at calculations and numerical analysis. But they can’t read people’s emotions as well as we can, or do much of anything useful with that information.... Read more »
Deborah Dunsire, the former head of Millennium Pharmaceuticals and a well-known Boston biotech veteran, is no longer the CEO of Forum Pharmaceuticals, Xconomy has learned.
Dunsire’s last day at Waltham, MA-based Forum was on Friday. She told Xconomy she’s formed a... Read more »